Scarica l'app Stockscreener
2.165
8.26%
-0.195
Pre-mercato:
2.15
-0.015
-0.69%
Precedente Chiudi:
$2.36
Aprire:
$2.37
Volume 24 ore:
4.03M
Relative Volume:
0.72
Capitalizzazione di mercato:
$200.76M
Reddito:
-
Utile/perdita netta:
$-69.31M
Rapporto P/E:
-1.7047
EPS:
-1.27
Flusso di cassa netto:
$-62.80M
1 W Prestazione:
-18.91%
1M Prestazione:
-75.65%
6M Prestazione:
-55.45%
1 anno Prestazione:
-57.96%
Intervallo 1D:
$2.1225
$2.43
Intervallo di 1 settimana:
$2.1225
$2.65
Portata 52W:
$1.07
$11.46
Rezolute Inc Stock (RZLT) Company Profile
Nome
Rezolute Inc
Settore
Industria
Telefono
650-206-4507
Indirizzo
275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY
Confronta RZLT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RZLT
Rezolute Inc
|
2.165 | 218.84M | 0 | -69.31M | -62.80M | -1.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.13 | 115.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.31 | 81.12B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.17 | 52.54B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
839.99 | 51.78B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.12 | 37.12B | 447.02M | -1.18B | -906.14M | -6.1812 |
Rezolute Inc Stock (RZLT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-11 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2025-12-11 | Downgrade | Craig Hallum | Buy → Hold |
| 2025-12-11 | Downgrade | Wedbush | Outperform → Neutral |
| 2024-11-05 | Iniziato | Wedbush | Outperform |
| 2024-08-27 | Iniziato | Guggenheim | Buy |
| 2024-07-17 | Iniziato | BTIG Research | Buy |
| 2024-06-04 | Iniziato | Craig Hallum | Buy |
| 2024-04-09 | Iniziato | Maxim Group | Buy |
| 2022-08-02 | Ripresa | Canaccord Genuity | Buy |
| 2022-06-15 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-09-08 | Iniziato | ROTH Capital | Buy |
| 2021-05-27 | Iniziato | Oppenheimer | Outperform |
| 2021-05-25 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Rezolute Inc Borsa (RZLT) Ultime notizie
INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RZLT - FinancialContent
Rezolute’s Phase 3 SunRIZE study for Ersodetug fails to meet primary and secondary endpoints despite analyst backing - MSN
Investigation Underway: Rezolute, Inc. (RZLT)Contact Levi & Korsinsky Over Securities Law Violations - ACCESS Newswire
Weekly Trades: Will Rezolute Inc 6HV1 stock test record highs in 20252025 Historical Comparison & Free AI Powered Buy and Sell Recommendations - moha.gov.vn
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rezolute, Inc.RZLT - PR Newswire
Rezolute shares in focus after RA Capital discloses 9.9% stake - MSN
Revenue per share of Rezolute, Inc. – FWB:6HV1 - TradingView — Track All Markets
Investors in Rezolute, Inc. (RZLT) Warned of Potential Securities FraudContact Levi & Korsinsky Today - ACCESS Newswire
Rezolute's Phase 3 sunRIZE Study for Ersodetug Fails to Meet Primary and Secondary Endpoints Despite Analyst Backing - Finviz
INVESTIGATION: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RZLT - The Malaysian Reserve
Rezolute’s Phase 3 sunRIZE Study for Ersodetug Fails to Meet Primary and Secondary Endpoints Despite Analyst Backing - Insider Monkey
Rezolute, Inc. (RZLT) Shares Tank 90% Amid Lead Asset Trial Fail - GuruFocus
Lost Money on Rezolute, Inc. (RZLT)? Possible FraudContact Levi & Korsinsky Today - ACCESS Newswire
Rezolute Faces Investor Outrage Amid Legal Scrutiny Following Trial Setback - StocksToTrade
About Us | Oil & Gas JournalRezolute, Inc.Common Stock (NV) (Nasdaq:RZLT) Stock Quote - FinancialContent
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rezolute, Inc. ... - Bluefield Daily Telegraph
Rezolute Faces Legal Scrutiny Following Disastrous Clinical Trial Results - timothysykes.com
Investigation Alert: Levi & Korsinsky Investigates Securities Fraud Claims Against Rezolute, Inc. (RZLT) - ACCESS Newswire
Rezolute, Inc. (RZLT) Shares Tank 90% Amid Lead Asset Trial Failure -- Hagens Berman Investigating - PR Newswire
Ongoing Rezolute, Inc. (RZLT) Investigation: Protect Your Rights – Contact Levi & Korsinsky - ACCESS Newswire
Rezolute Stock: A Deluge of Turmoil - StocksToTrade
RZLT ALERT: Levi & Korsinsky Investigates Rezolute, Inc. for Possible Securities Fraud Violations - ACCESS Newswire
INVESTIGATION ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - TMX Newsfile
Rezolute downgraded to neutral from overweight at Cantor Fitzgerald - MSN
Investigation Opened on Behalf of Rezolute, Inc. (RZLT) ShareholdersContact Levi & Korsinsky - ACCESS Newswire
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - The National Law Review
ATTENTION RZLT Shareholders: Lost Money on Rezolute, Inc.? Contact Levi & Korsinsky About Investigation - ACCESS Newswire
Ongoing Investigation into Rezolute, Inc. (RZLT): Contact Levi & Korsinsky About Potential Fraud - ACCESS Newswire
Jefferies’ Bullish Price Target Boosts Rezolute Amid Congenital Hyperinsulinism Data Anticipation - StocksToTrade
RZLT Stock Surge: Buy or Let Go? - StocksToTrade
Jefferies Raises Rezolute Target to Spur Stock Optimism - timothysykes.com
Investors Purchase Large Volume of Rezolute Put Options (NASDAQ:RZLT) - MarketBeat
Rezolute, Inc. (RZLT) Stock News and Forecasts on Dec. 24, 2025: Phase 3 sunRIZE Miss, Analyst Target Cuts, and What Comes Next - ts2.tech
Ongoing Rezolute, Inc. (RZLT) Investigation: Protect Your RightsContact Levi & Korsinsky - ACCESS Newswire
RZLT ALERT: Ongoing Investigation Into Rezolute, Inc.Contact Levi & Korsinsky - ACCESS Newswire
Levi & Korsinsky Investigating Whether Rezolute, Inc. (RZLT) Misled InvestorsSecurities Law Violations Possible - ACCESS Newswire
INVESTIGATION NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - The Malaysian Reserve
Down 81.8% in 4 weeks, here's why Rezolute (RZLT) looks ripe for a turnaround - MSN
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Rezolute Earnings Notes - Trefis
Levi & Korsinsky Launches Fraud Investigation on Behalf of Rezolute, Inc. (RZLT) Shareholders - ACCESS Newswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Beha - GuruFocus
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - 巴士的報
Rezolute (RZLT) price target decreased by 61.18% to 6.25 - MSN
Can Rezolute Inc. stock deliver surprise earnings beat2025 Price Action Summary & Advanced Swing Trade Entry Alerts - Улправда
How geopolitical tensions affect Rezolute Inc. stockJuly 2025 Retail & Low Drawdown Momentum Ideas - ulpravda.ru
Is Rezolute Inc. (6HV1) stock included in top ETFs2025 Volatility Report & Growth Oriented Trading Recommendations - Улправда
RZLT ALERT: Levi & Korsinsky Investigates Rezolute, Inc. on Behalf of Shareholders Who Lost Money - ACCESS Newswire
REZOLUTE INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RZLT - GlobeNewswire
Rezolute (RZLT) Misses Key CHI Endpoints: Does Ersodetug’s TIH Pivot Rewrite The Drug’s Story? - simplywall.st
Is Rezolute Inc. stock a buy in volatile markets2025 Bull vs Bear & Low Drawdown Investment Ideas - DonanımHaber
Rezolute Inc Azioni (RZLT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Rezolute Inc Azioni (RZLT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| ROBERTS BRIAN KENNETH | Chief Medical Officer |
Dec 16 '25 |
Buy |
1.70 |
28,000 |
47,600 |
308,352 |
| Evans Daron | CFO |
Dec 15 '25 |
Buy |
1.77 |
40,000 |
70,640 |
415,900 |
| Evans Daron | CFO |
Dec 15 '25 |
Buy |
1.79 |
5,000 |
8,938 |
7,000 |
| Elam Nevan C | CEO |
Dec 15 '25 |
Buy |
1.59 |
32,000 |
50,880 |
641,119 |
| Karnawat Sunil Ratilal | Chief Commercial Officer |
Dec 15 '25 |
Buy |
1.62 |
12,100 |
19,599 |
71,542 |
| ROBERTS BRIAN KENNETH | Chief Medical Officer |
Jun 25 '25 |
Buy |
4.38 |
2,500 |
10,939 |
15,500 |
| Evans Daron | CFO |
Jun 24 '25 |
Buy |
4.05 |
5,000 |
20,250 |
268,900 |
| Kim Young-Jin | Director |
Jun 13 '25 |
Buy |
3.25 |
1,230,769 |
3,999,999 |
8,423,386 |
| KREHER NERISSA | Director |
Jun 13 '25 |
Buy |
3.25 |
3,076 |
9,997 |
37,576 |
| Hogenhuis Wladimir | Director |
Mar 31 '25 |
Buy |
2.92 |
6,758 |
19,733 |
84,025 |
0.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):